4.7 Article

Stenotrophomonas maltophilia pneumonia in critical COVID-19 patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Virology

Impact of ABO and Rhesus blood groups on COVID-19 susceptibility and severity: A case-control study

Anthony Kerbage et al.

Summary: Early evidence from China suggested that blood groups may play a role in COVID-19 susceptibility, with A Rh+ blood type being associated with increased risk. However, our study found that while A Rh+ blood type increases susceptibility to COVID-19, it is not associated with higher disease severity. No significant relationship was found between COVID-19 and other blood groups.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Medicine, General & Internal

Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review

Kazuhiro Ishikawa et al.

Summary: The objective of this study was to identify the risk factors for Stenotrophomonas maltophilia infection in patients with COVID-19. Through the analysis of four cases, it was found that the isolation of S. maltophilia in respiratory specimens of COVID-19 patients should prompt clinicians to administer appropriate treatment.

AMERICAN JOURNAL OF CASE REPORTS (2022)

Article Medicine, General & Internal

Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy

Masaatsu Kuwahara et al.

Summary: This paper reports the recovery of a patient with severe COVID-19 after antimicrobial treatment for Stenotrophomonas maltophilia bacteremia.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Article Infectious Diseases

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

Richard G. Wunderink et al.

Summary: Cefiderocol was found to be non-inferior to high-dose, extended-infusion meropenem in terms of all-cause mortality on day 14 in patients with Gram-negative nosocomial pneumonia, with similar tolerability. This suggests that cefiderocol is a potential option for the treatment of patients with nosocomial pneumonia, including those caused by multidrug-resistant Gram-negative bacteria.

LANCET INFECTIOUS DISEASES (2021)

Article Critical Care Medicine

Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia

Chiagozie O. Pickens et al.

Summary: In patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation, bacterial superinfection occurs in 25% of patients at the time of intubation. Empirical antibiotic management based on guidelines leads to antibiotic overuse, while BAL-based management reduces antibiotic use significantly. VAP develops in 44% of patients and accurate identification relies on microbiologic analysis of BAL fluid.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Infectious Diseases

Ventilator-Associated Pneumonia in COVID-19 Patients: A Retrospective Cohort Study

Maxence Rouyer et al.

Summary: The study showed that ventilator-associated pneumonia (VAP) in COVID-19 patients is associated with shock, bloodstream infections, and polymicrobial infections.

ANTIBIOTICS-BASEL (2021)

Article Critical Care Medicine

Ventilator-associated pneumonia in critically ill patients with COVID-19

Mailis Maes et al.

Summary: This study found that COVID-19 patients were more likely to develop VAP, with 3 cases of invasive aspergillosis identified among them and herpesvirade activation being more frequent. The causative organisms of secondary pneumonia observed were similar between COVID-19 and non-COVID-19 patients, suggesting a link to pulmonary dysbiosis caused by COVID-19.

CRITICAL CARE (2021)

Article Public, Environmental & Occupational Health

Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients

C. H. Wang et al.

JOURNAL OF HOSPITAL INFECTION (2020)

Article Infectious Diseases

Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome

Wafa Ibn Saied et al.

JOURNAL OF INFECTION (2020)

Letter Respiratory System

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19

Frederikus A. Klok et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Article Public, Environmental & Occupational Health

Cluster of S. maltophilia among patients with respiratory tract infections at an intensive care unit

Maria Gideskog et al.

INFECTION PREVENTION IN PRACTICE (2020)

Article Respiratory System

Pneumothorax in COVID-19 disease- incidence and clinical characteristics

Massa Zantah et al.

RESPIRATORY RESEARCH (2020)

Letter Medicine, General & Internal

The National Early Warning Score 2 (NEWS2)

Gary B. Smith et al.

CLINICAL MEDICINE (2019)

Review Infectious Diseases

Stenotrophomonas maltophilia biofilm: its role in infectious diseases

Samantha Flores-Trevino et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019)

Article Public, Environmental & Occupational Health

Pseudo-outbreaks of Stenotrophomonas maltophilia on an intensive care unit in England

T. D. Waite et al.

JOURNAL OF HOSPITAL INFECTION (2016)

Review Microbiology

Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

Joanna S. Brooke

CLINICAL MICROBIOLOGY REVIEWS (2012)

Article Infectious Diseases

Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients

B. Saugel et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)

Article Public, Environmental & Occupational Health

Risk Factors for Mortality in Patients with Nosocomial Stenotrophomonas maltophilia Pneumonia

Chia-Cheng Tseng et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)

Review Infectious Diseases

Stenotrophomonas maltophilia: an emerging opportunist human pathogen

W. John Looney et al.

LANCET INFECTIOUS DISEASES (2009)

Article Immunology

Stenotrophomonas maltophilia intestinal colonization in hospitalized oncology patients with diarrhea

A Apisarnthanarak et al.

CLINICAL INFECTIOUS DISEASES (2003)